Salidroside Protects Dopaminergic Neurons by Regulating the Mitochondrial MEF2D-ND6 Pathway in the MPTP/MPP+ -Induced Model of Parkinson’s Disease.

Salidroside Protects Dopaminergic Neurons by Regulating the Mitochondrial MEF2D-ND6 Pathway in the MPTP/MPP+ -Induced Model of Parkinson’s Disease.
Salidroside Protects Dopaminergic Neurons by Regulating the Mitochondrial MEF2D-ND6 Pathway in the MPTP/MPP+ -Induced Model of Parkinson's Disease. J Neurochem. 2019 Sep 14;: Authors: Li T, Zhang W, Kang X, Yang R, Li R, Huang L, Chen J, Yang Q, Sun X Abstract Mitochondrial complex I damage and oxidative stress play critical roles in the degeneration of dopaminergic (DA) neurons ... read more
Source: PubMedPublished on 2019-09-15